David R. Liu is the Richard Merkin Professor, Director of the Merkin Institute of Transformative Technologies in Healthcare, and Vice-Chair of the Faculty at the Broad Institute of Harvard and MIT; Thomas Dudley Cabot Professor of the Natural Sciences and Professor of Chemistry and Chemical Biology at Harvard University; and Howard Hughes Medical Institute Investigator.

‍

Liu graduated first in his class at Harvard in 1994.

‍

他在本科时就在E. J. Corey教授的指导下进行了甾醇生物合成的有机和生物有机化学研究。在加州大学伯克利分校与彼得-舒尔茨教授进行博士研究期间，柳传志发起了第一个在活细胞中扩展遗传密码的总体努力。他于1999年获得博士学位，同年成为哈佛大学化学和化学生物学的助理教授。2003年他被提升为副教授，2005年成为正教授。刘在2005年成为霍华德-休斯医学研究所研究员，并在2009年加入美国政府的学术科学顾问JASONs。刘教授在哈佛大学的教学中获得了多项荣誉，包括约瑟夫-R-莱文森纪念教学奖、罗斯林-艾布拉姆森奖和哈佛大学教授资格。柳传志已经发表了165篇论文，是60多项美国专利的发明人。

‍

His research accomplishments have earned distinctions including the Ronald Breslow Award for Biomimetic Chemistry, the American Chemical Society Pure Chemistry Award, the Arthur C. Cope Young Scholar Award, and awards from the Sloan Foundation, Beckman Foundation, NSF CAREER Program, and Searle Scholars Program.

‍

In 2016 he was named one of the Top 20 Translational Researchers in the world by Nature Biotechnology, and in 2017 was named to the Nature’s 10 researchers in world and to the Foreign Policy Leading Global Thinkers.

‍

Professor Liu’s research integrates chemistry and evolution to illuminate biology and enable next-generation therapeutics. His major research interests include the engineering, evolution, and in vivo delivery of genome editing proteins such as base editors to study and treat genetic diseases; the evolution of proteins with novel therapeutic potential using phage-assisted continuous evolution (PACE); and the discovery of bioactive synthetic small molecules and synthetic polymers using DNA-templated organic synthesis and DNA-encoded libraries. Base editing (named one of four 2017 Breakthrough of the Year finalists by Science), PACE, and DNA-templated synthesis are three examples of technologies pioneered in his laboratory. He is the scientific founder or co-founder of six biotechnology and therapeutics companies, including Editas Medicine, Pairwise Plants, and Beam Therapeutics.

‍

刘也是一个狂热的摄影师，已经超过25年了。